Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
      Description

      This is a Phase 1 dose escalation study of an investigational agent, everolimus, given in combination with standard radiation therapy, in prostate cancers with a rising PSA following a prostatectomy. A maximum of 33 people will be enrolled on this study at the University of Pennsylvania. The primary objective of this study is to determine the acute and chronic toxicities and maximum tolerated dose of everolimus with concurrent radiation.

      Conditions
      Prostate Cancer Patients With Detectable PSA Following Prostatectomy
      Talk to us
      RECRUITING
      64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
      Description

      The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer

      Conditions
      Prostate CancerProstate Cancer Patients With Detectable PSA Following ProstatectomyProstate Cancer RecurrentProstate Cancer Patients Who Have Brachytherapy Seed ImplantProstate Cancer Patients Treated by RadiotherapyCryotherapy
      Talk to us